Patou Gary's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Nov 22, 2024
- Accession no.
- 0000950170-24-130378
- Filed
- Nov 22, 2024
- Trade date
- Nov 22, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $200.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patou GaryCIK 0001283535 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Shares | MOption exerciseAcquired | +3,500 | $7.38 | +$25,830 | 27,073 | Direct | |
| Nov 22, 2024 | Common Shares | FTax withholdingDisposed | −649 | $39.80 | −$25,830.2 | 26,424 | Direct | |
| Nov 22, 2024 | Common Shares | SSaleDisposed | −2,851 | $41.11 | −$117,204.61 | 23,573 | Direct | |
| Nov 22, 2024 | Common Shares | MOption exerciseAcquired | +3,086 | $13.48 | +$41,599.28 | 26,659 | Direct | |
| Nov 22, 2024 | Common Shares | FTax withholdingDisposed | −1,046 | $39.80 | −$41,630.8 | 25,613 | Direct | |
| Nov 22, 2024 | Common Shares | SSaleDisposed | −2,040 | $41.05 | −$83,742 | 23,573 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Shares | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 0 | Direct | |
| Nov 22, 2024 | Common Shares | MOption exerciseDisposed | −3,086 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.